Patients with mite and pellitory allergies also showed a significant VAS reduction after the first year of MC-SCIT compared with that before treatment ( p < 0.05), whereas the change in VAS did not reach statistical significance in patients with grass allergies.
← all excerpts
Real-Life Effectiveness of Subcutaneous Immune Therapy with Carbamylated Monomeric Allergoids on Mite, Grass, and Pellitory Respiratory Allergy: A Retrospective Study.
1
—
—